AU2001281992A1 - 2,2-disubstituted 1,3-dioxolanes as antitussive agents - Google Patents

2,2-disubstituted 1,3-dioxolanes as antitussive agents

Info

Publication number
AU2001281992A1
AU2001281992A1 AU2001281992A AU8199201A AU2001281992A1 AU 2001281992 A1 AU2001281992 A1 AU 2001281992A1 AU 2001281992 A AU2001281992 A AU 2001281992A AU 8199201 A AU8199201 A AU 8199201A AU 2001281992 A1 AU2001281992 A1 AU 2001281992A1
Authority
AU
Australia
Prior art keywords
dioxolanes
disubstituted
antitussive agents
piperazinyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001281992A
Inventor
Marcello Allegretti
Maria Candida Cesta
Roberto Curti
Luca Nicolini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dompe SpA
Original Assignee
Dompe SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe SpA filed Critical Dompe SpA
Publication of AU2001281992A1 publication Critical patent/AU2001281992A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Holo Graphy (AREA)
  • Glass Compositions (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Secondary Cells (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Fats And Perfumes (AREA)
  • Liquid Crystal Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

(±) 3-(4-Phenyl-1-piperazinyl)-1,2-propanediol cyclic acetals, a process for the optical resolution thereof and their use as intermediates for the preparation of (-) 3-(4-phenyl-1-piperazinyl)-1,2-propanediol (levodropropizine) and salts thereof are described herein.
AU2001281992A 2000-07-28 2001-07-18 2,2-disubstituted 1,3-dioxolanes as antitussive agents Abandoned AU2001281992A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI200A001735 2000-07-28
IT2000MI001735A IT1318651B1 (en) 2000-07-28 2000-07-28 SUMMARY OF (+ -) 1,3-DIOSSOLANS AND THEIR OPTICAL RESOLUTION.
PCT/EP2001/008305 WO2002010150A1 (en) 2000-07-28 2001-07-18 2,2-disubstituted 1,3-dioxolanes as antitussive agents

Publications (1)

Publication Number Publication Date
AU2001281992A1 true AU2001281992A1 (en) 2002-02-13

Family

ID=11445592

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001281992A Abandoned AU2001281992A1 (en) 2000-07-28 2001-07-18 2,2-disubstituted 1,3-dioxolanes as antitussive agents

Country Status (25)

Country Link
US (1) US6916926B2 (en)
EP (1) EP1307440B1 (en)
JP (1) JP5015403B2 (en)
KR (1) KR100788532B1 (en)
CN (1) CN1216053C (en)
AT (1) ATE290533T1 (en)
AU (1) AU2001281992A1 (en)
BR (1) BR0112802A (en)
CZ (1) CZ301039B6 (en)
DE (1) DE60109299T2 (en)
EE (1) EE05159B1 (en)
ES (1) ES2237589T3 (en)
HK (1) HK1058798A1 (en)
HU (1) HU229801B1 (en)
IL (2) IL153502A0 (en)
IT (1) IT1318651B1 (en)
MX (1) MXPA02012922A (en)
PL (1) PL206308B1 (en)
PT (1) PT1307440E (en)
RS (1) RS50862B (en)
RU (1) RU2269522C2 (en)
SI (1) SI21041B (en)
SK (1) SK286795B6 (en)
UA (1) UA73790C2 (en)
WO (1) WO2002010150A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318650B1 (en) * 2000-07-28 2003-08-27 Dompe Spa 1,3-DIOSSOLANS WITH ANTI-TOXIC ACTIVITY.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049660A (en) * 1971-06-18 1977-09-20 Delalande S.A. N-substituted derivatives of 4 (N-piperazinylmethyl) spiro dibenzocycloheptadi- (or tri-) ene-5, 2-dioxolane (1,3) their method of preparation and their application in therapeutics
IT1210639B (en) * 1981-02-25 1989-09-14 Menarini Sas PRODUCT: 3 (4-FENIL1PIPERAZINIO-1-IL) -1,2-PROPANDIOL 3 (TEOFILLIN-7-IL) -1PROPANSULFONATE, USABLE IN THERAPY, AND RELATED MANUFACTURING PROCEDURE
IT1203721B (en) * 1983-12-29 1989-02-23 Dompe Farmaceutici Spa OPTICALLY ACTIVE COMPOUNDS WITH ANTITOSSE AND CENTRAL SEDATIVE ACTIVITIES, PROCEDURE FOR PREPARATION AND COMPOSITIONS CONTAINING THEM
SE449516B (en) * 1984-10-16 1987-05-04 Skf Nova Ab CLAMP RING WITH ADJUSTABLE HALOM CIRCUIT
IT1254452B (en) * 1992-02-14 1995-09-25 Dompe Farmaceutici Spa N-OXIDES AND N, N'-DIOXIDES OF 3- (PIPERAZIN-1-IL) -PROPAN-1,2-DIOLS
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IT1318650B1 (en) * 2000-07-28 2003-08-27 Dompe Spa 1,3-DIOSSOLANS WITH ANTI-TOXIC ACTIVITY.

Also Published As

Publication number Publication date
EE200300035A (en) 2004-10-15
ITMI20001735A1 (en) 2002-01-28
ES2237589T3 (en) 2005-08-01
IL153502A (en) 2006-12-10
CZ301039B6 (en) 2009-10-21
UA73790C2 (en) 2005-09-15
KR20030016424A (en) 2003-02-26
JP2004505074A (en) 2004-02-19
SI21041B (en) 2005-08-31
DE60109299D1 (en) 2005-04-14
HU229801B1 (en) 2014-07-28
CN1216053C (en) 2005-08-24
US6916926B2 (en) 2005-07-12
BR0112802A (en) 2003-07-01
HK1058798A1 (en) 2004-06-04
ATE290533T1 (en) 2005-03-15
EP1307440A1 (en) 2003-05-07
RS50862B (en) 2010-08-31
MXPA02012922A (en) 2003-10-06
ITMI20001735A0 (en) 2000-07-28
US20030176446A1 (en) 2003-09-18
PL206308B1 (en) 2010-07-30
HUP0301473A2 (en) 2003-08-28
SI21041A (en) 2003-04-30
DE60109299T2 (en) 2005-07-21
SK902003A3 (en) 2003-09-11
PL361173A1 (en) 2004-09-20
JP5015403B2 (en) 2012-08-29
YU3103A (en) 2006-05-25
WO2002010150A1 (en) 2002-02-07
CN1444579A (en) 2003-09-24
CZ2003269A3 (en) 2003-06-18
PT1307440E (en) 2005-05-31
EE05159B1 (en) 2009-04-15
IT1318651B1 (en) 2003-08-27
IL153502A0 (en) 2003-07-06
RU2269522C2 (en) 2006-02-10
SK286795B6 (en) 2009-05-07
EP1307440B1 (en) 2005-03-09
KR100788532B1 (en) 2007-12-24

Similar Documents

Publication Publication Date Title
MX9603050A (en) 1-h-3-arylpyrrolidine-2,4-dione derivatives as pest-control agents.
EA200300459A1 (en) NEW, AS ANTICOLINERGIC MEDICINES USED AS MEDICINES, AND ALSO THE METHOD OF THEIR PREPARATION
NO870241L (en) HYPOGLYCHEMICAL TIAZOLIDE INDIA.
DK0639186T3 (en) Taxol derivatives
DK0776324T3 (en) Endothelin antagonists
DK0923554T3 (en) N-Benzylpiperidine and tetrahydropyridine derivatives
AR002157A1 (en) USE OF AN EFFECTIVE IMMUNIZING DOSE OF LIVE EIMERIA ESPOROZOITES OR MEROZOITES, OR A MIXTURE OF THE SAME
BR0114380A (en) 1-Aminobutan-3-ol-substituted derivatives
AU6220300A (en) Benzofurylpiperazine serotonin agonists
DE50101861D1 (en) TOCOTRIENOLCHINONE CYCLIZING PRODUCTS WITH ANTIHYPERCHOLESTERINE EFFECT
AU2001281992A1 (en) 2,2-disubstituted 1,3-dioxolanes as antitussive agents
EP0790252A4 (en) Fumaric acid derivative and polymer thereof
EA200201003A1 (en) AMORPHOUS MODIFICATION OF THORASEMIDE
AU2001287638A1 (en) 1,3-dioxolanes with antitussive activity
HK1036791A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
ATE298336T1 (en) METHOD FOR PRODUCING THIAZOLIDINEDIONE DERIVATIVES AND INTERMEDIATE PRODUCTS
EA200200741A1 (en) METHOD OF OBTAINING ETHERS OF ARYLIMINOMETHYLKARBAMINIC ACID
EA200200090A1 (en) METHOD OF OBTAINING SUBSTITUTED BENZYZOTHIAOSOL COMPOUNDS